Complementary pre-screening strategies to uncover hidden prodromal and mild Alzheimer's disease: Results from the MOPEAD project.
Alzheimer's disease
diagnostic gap
early diagnosis
patient engagement
population-based screening
Journal
Alzheimer's & dementia : the journal of the Alzheimer's Association
ISSN: 1552-5279
Titre abrégé: Alzheimers Dement
Pays: United States
ID NLM: 101231978
Informations de publication
Date de publication:
06 2022
06 2022
Historique:
revised:
02
07
2021
received:
03
09
2020
accepted:
05
07
2021
pubmed:
27
7
2021
medline:
9
6
2022
entrez:
26
7
2021
Statut:
ppublish
Résumé
The Models of Patient Engagement for Alzheimer's Disease (MOPEAD) project was conceived to explore innovative complementary strategies to uncover hidden prodromal and mild Alzheimer's disease (AD) dementia cases and to raise awareness both in the general public and among health professionals about the importance of early diagnosis. Four different strategies or RUNs were used: (a) a web-based (WB) prescreening tool, (2) an open house initiative (OHI), (3) a primary care-based protocol for early detection of cognitive decline (PC), and (4) a tertiary care-based pre-screening at diabetologist clinics (DC). A total of 1129 patients at high risk of having prodromal AD or dementia were identified of 2847 pre-screened individuals (39.7%). The corresponding proportion for the different initiatives were 36.8% (WB), 35.6% (OHI), 44.4% (PC), and 58.3% (DC). These four complementary pre-screening strategies were useful for identifying individuals at high risk of having prodromal or mild AD.
Identifiants
pubmed: 34310061
doi: 10.1002/alz.12441
pmc: PMC9290633
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1119-1127Informations de copyright
© 2021 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.
Références
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Alzheimers Dement. 2014 Nov;10(6):844-52
pubmed: 24798886
Lancet. 2018 Nov 17;392(10160):2214-2228
pubmed: 30314860
J Am Geriatr Soc. 2003 May;51(5 Suppl Dementia):S281-8
pubmed: 12801384
Lancet Neurol. 2016 Apr;15(5):455-532
pubmed: 26987701
J Neurol Neurosurg Psychiatry. 2009 Feb;80(2):133-9
pubmed: 18977819
Alzheimers Dement. 2022 Jun;18(6):1119-1127
pubmed: 34310061
Alzheimers Dement. 2021 Aug;17(8):1307-1316
pubmed: 33860599
J Alzheimers Dis. 2009;16(4):677-85
pubmed: 19387104
Lancet Diabetes Endocrinol. 2013 Nov;1(3):183-90
pubmed: 24622366
J Alzheimers Dis. 2020;76(1):33-40
pubmed: 32538856
J Alzheimers Dis. 2017;57(2):625-632
pubmed: 28269773
J Alzheimers Dis. 2015 Sep 24;48 Suppl 1:S99-S107
pubmed: 26402087
Alzheimers Dement. 2019 Jun;15(6):828-839
pubmed: 31076376
Diabetes Care. 2013 Jun;36(6):1554-61
pubmed: 23275366
Neuropsychologia. 2001;39(11):1150-7
pubmed: 11527552
Neurology. 1988 Jun;38(6):900-3
pubmed: 3368071
Arch Gen Psychiatry. 2010 Apr;67(4):414-22
pubmed: 20368517